Amanda Lang in an interview with Brad Sorensen of Providence Therapeutics asserted that the federal government has not supported Providence's vaccine efforts. He did not correct her. In fact, the National Research Council has given Providence $4.7M for Phase I trial. /2 #cdnpoli

2/ That trial is underway. As for Manitoba, it has ordered doses from Providence that it might receive in 2022, well after vaccines from actual producers (Providence does not manufacture) have adequately supplied Manitoba. /3

3/ Mr. Sorensen says that if Manitoba doesn't need Providence's vaccine, assuming that it is successful, he hopes to export into the global market, at which point MB will recoup its investment. Details about that unclear. /4

4/ Where Providence intends to manufacture its possibly successful vaccine is still not clear...

And just for general information, the Providence Phase I trial involves 60 volunteers. The purpose of Phase I trials is to evaluate safety (site-of-injection issues, side-effects, etc.) and to refine dosage. It does not test vaccine efficacy against Covid-19.